TrialFrontiers of medicine2019

Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia.

Xiaoxiao Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.